Radiofrequency ablation improves survival over SBRT in localised hepatocellular carcinoma

Radiofrequency ablation was associated with superior 5-year overall survival compared with stereotactic body radiotherapy for patients with localised hepatocellular carcinoma, according to an observational study published in the Journal of Clinical Oncology.
OncLive